Disc Medicine, Inc.
Key Metrics
Market Snapshot
About
Disc Medicine is a clinical-stage biopharmaceutical company focused on developing novel treatments for patients with serious hematologic diseases. The company's research centers on diseases of red blood cell biology, including anemia and iron metabolism disorders. Disc Medicine's pipeline includes therapies targeting conditions such as myelodysplastic syndromes (MDS), myelofibrosis, and other blood disorders. The company utilizes its understanding of hepcidin biology and iron regulation to develop innovative therapeutic approaches. Their lead programs aim to address significant unmet medical needs in hematology.